41
Participants
Start Date
January 23, 2017
Primary Completion Date
March 12, 2020
Study Completion Date
March 12, 2020
Blinatumomab
Blinatumomab monotherapy
Research Site, Brussels
Research Site, St Leonards
Research Site, Leuven
Research Site, Melbourne
Research Site, Parkville
Research Site, Herston
Research Site, Murdoch
Research Site, Ghent
Research Site, Córdoba
Research Site, Santiago de Compostela
Research Site, Genova
Research Site, Baltimore
Research Site, Bergamo
Research Site, Madrid
Research Site, Madrid
Research Site, Greenville
Research Site, Murcia
Research Site, Udine
Research Site, Valladolid
Research Site, Florence
Research Site, Pisa
Research Site, Oklahoma City
Research Site, Palermo
Research Site, Duarte
Research Site, Montreal
Research Site, Roma
Research Site, San Juan
Research Site, Barcelona
Research Site, Bristol
Research Site, Nottingham
Research Site, Sheffield
Lead Sponsor
Amgen
INDUSTRY